Rakuten

Rakuten, founded in Japan in 1997, is a global leader in internet services. It operates across three segments: Internet Services (e-commerce platforms, travel booking sites, digital content), Finance Services (banking, securities, credit cards, insurance), and Communications Services (mobile data communication, telecommunications). Rakuten's mission is to empower people and society through the internet, with a presence in over 30 countries and a diverse ecosystem of 80 digital services.

Saemin Ahn

Managing Partner, Rakuten Ventures

Hogil Doh

Investor

Masatada Kobayashi

Group Managing Executive Officer and Chief Well-Being Officer

Mickey Mikitani

Founder, Chairman and CEO

Michael Piechalak

Partner, Rakuten FinTech Fund / Rakuten Mobility Investments

Adit Swarup

Principal

Hiroshi Takasawa

President, Investments

Yoshihisa Yamada

Senior Executive Officer and Director

Kazuyoshi Abumi

Executive Officer

Past deals in Taiwan

Rakuten Medical

Series E in 2024
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

Rakuten Medical

Series D in 2021
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

ShopBack

Series B in 2020
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Rakuten Medical

Series C in 2019
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

ShopBack

Series B in 2019
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Rakuten Medical

Series C in 2018
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

Rakuten Medical

Series C in 2018
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

Carousell

Series C in 2018
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Genesis Healthcare

Venture Round in 2018
Genesis Healthcare Co. is a privately-owned genetic testing and research company founded in 2004 and headquartered in Tokyo, Japan, with additional offices in Singapore and Taiwan. The company is recognized as a market leader in consumer genetics in Japan, offering its services under the brand "GeneLife." Genesis Healthcare possesses the largest genetic database in Japan and Asia, encompassing over 988,000 individuals and more than 1,500 diseases. The company utilizes advanced technologies such as PCR, Microarray, and NGS for research and clinically validated genetic testing services. In addition to its commercial offerings, Genesis Healthcare collaborates with government agencies to establish genetic testing guidelines, ensuring accuracy and the protection of individuals' genetic information. By promoting preventive healthcare through genetic testing, Genesis Healthcare aims to enhance public health outcomes across Southeast Asia.

Genesis Healthcare

Venture Round in 2017
Genesis Healthcare Co. is a privately-owned genetic testing and research company founded in 2004 and headquartered in Tokyo, Japan, with additional offices in Singapore and Taiwan. The company is recognized as a market leader in consumer genetics in Japan, offering its services under the brand "GeneLife." Genesis Healthcare possesses the largest genetic database in Japan and Asia, encompassing over 988,000 individuals and more than 1,500 diseases. The company utilizes advanced technologies such as PCR, Microarray, and NGS for research and clinically validated genetic testing services. In addition to its commercial offerings, Genesis Healthcare collaborates with government agencies to establish genetic testing guidelines, ensuring accuracy and the protection of individuals' genetic information. By promoting preventive healthcare through genetic testing, Genesis Healthcare aims to enhance public health outcomes across Southeast Asia.

Rakuten Medical

Series B in 2017
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

Carousell

Series B in 2016
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Rakuten Medical

Series B in 2016
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

Carousell

Series B in 2016
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Rakuten Medical

Series A in 2015
Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

Carousell

Series A in 2014
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Carousell

Series A in 2014
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Carousell

Seed Round in 2013
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Carousell

Seed Round in 2013
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.